These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 29031731)

  • 41. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation.
    Xu Y; Wu Z; Sun H; Zhu Y; Kim ER; Lowell BB; Arenkiel BR; Xu Y; Tong Q
    Cell Metab; 2013 Dec; 18(6):860-70. PubMed ID: 24315371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
    Zemel MB; Shi H
    Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide.
    Heyder NA; Kleinau G; Speck D; Schmidt A; Paisdzior S; Szczepek M; Bauer B; Koch A; Gallandi M; Kwiatkowski D; Bürger J; Mielke T; Beck-Sickinger AG; Hildebrand PW; Spahn CMT; Hilger D; Schacherl M; Biebermann H; Hilal T; Kühnen P; Kobilka BK; Scheerer P
    Cell Res; 2021 Nov; 31(11):1176-1189. PubMed ID: 34561620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
    Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
    J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.
    Yaswen L; Diehl N; Brennan MB; Hochgeschwender U
    Nat Med; 1999 Sep; 5(9):1066-70. PubMed ID: 10470087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies.
    Wabitsch M; Fehnel S; Mallya UG; Sluga-O'Callaghan M; Richardson D; Price M; Kühnen P
    Adv Ther; 2022 Apr; 39(4):1772-1783. PubMed ID: 35192151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The central melanocortin system as a treatment target for obesity and diabetes: A brief overview.
    Goit RK; Taylor AW; Lo ACY
    Eur J Pharmacol; 2022 Jun; 924():174956. PubMed ID: 35430211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of α-MSH and AgRP axons to the perikarya of melanocortin-4 receptor neurons.
    Lima LB; Pedroso JAB; Metzger M; Gautron L; Donato J
    Brain Res; 2019 Aug; 1717():136-146. PubMed ID: 31009611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptor.
    Mansour M; White D; Wernette C; Dennis J; Tao YX; Collins R; Parker L; Morrison E
    Endocrine; 2010 Feb; 37(1):220-30. PubMed ID: 20963574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin Pathway.
    Kanti V; Puder L; Jahnke I; Krabusch PM; Kottner J; Vogt A; Richter C; Andruck A; Lechner L; Poitou C; Krude H; Gottesdiener K; Clément K; Farooqi IS; Wiegand S; Kühnen P; Blume-Peytavi U
    Skin Pharmacol Physiol; 2021; 34(6):307-316. PubMed ID: 34058738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants.
    Sharma S; Thibodeau S; Lytton J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165835. PubMed ID: 32423884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating.
    Lubrano-Berthelier C; Dubern B; Lacorte JM; Picard F; Shapiro A; Zhang S; Bertrais S; Hercberg S; Basdevant A; Clement K; Vaisse C
    J Clin Endocrinol Metab; 2006 May; 91(5):1811-8. PubMed ID: 16507637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
    Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
    Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular cloning, tissue distribution, and pharmacological characterization of melanocortin-4 receptor in spotted scat, Scatophagus argus.
    Li JT; Yang Z; Chen HP; Zhu CH; Deng SP; Li GL; Tao YX
    Gen Comp Endocrinol; 2016 May; 230-231():143-52. PubMed ID: 27080551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-dependent hypothalamic expression of neuropeptides in wild-type and melanocortin-4 receptor-deficient mice.
    Arens J; Moar KM; Eiden S; Weide K; Schmidt I; Mercer JG; Simon E; Korf HW
    Physiol Genomics; 2003 Dec; 16(1):38-46. PubMed ID: 14559977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.
    Fani L; Bak S; Delhanty P; van Rossum EF; van den Akker EL
    Int J Obes (Lond); 2014 Feb; 38(2):163-9. PubMed ID: 23774329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice.
    Clemmensen C; Finan B; Fischer K; Tom RZ; Legutko B; Sehrer L; Heine D; Grassl N; Meyer CW; Henderson B; Hofmann SM; Tschöp MH; Van der Ploeg LH; Müller TD
    EMBO Mol Med; 2015 Mar; 7(3):288-98. PubMed ID: 25652173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy.
    Buono P; Pasanisi F; Nardelli C; Ieno L; Capone S; Liguori R; Finelli C; Oriani G; Contaldo F; Sacchetti L
    Clin Chem; 2005 Aug; 51(8):1358-64. PubMed ID: 15951321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melanocortin-4 receptor mutations in obesity.
    Santini F; Maffei M; Pelosini C; Salvetti G; Scartabelli G; Pinchera A
    Adv Clin Chem; 2009; 48():95-109. PubMed ID: 19803416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.